↓ Skip to main content

Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial

Overview of attention for article published in BMC Cancer, May 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
Published in
BMC Cancer, May 2012
DOI 10.1186/1471-2407-12-185
Pubmed ID
Authors

Shiro Fujita, Nobuyuki Katakami, Katsuhiro Masago, Hiroshige Yoshioka, Keisuke Tomii, Toshihiko Kaneda, Masataka Hirabayashi, Kei Kunimasa, Toshio Morizane, Tadashi Mio

Abstract

Elderly patients are more vulnerable to toxicity from chemotherapy. Activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are associated with enhanced response to EGFR tyrosine-kinase inhibitors. We studied patients with advanced NSCLC for whom treatment was customized based on EGFR mutation status.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 24%
Student > Master 6 13%
Student > Ph. D. Student 6 13%
Student > Bachelor 5 11%
Other 5 11%
Other 5 11%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 20 43%
Agricultural and Biological Sciences 5 11%
Nursing and Health Professions 3 7%
Psychology 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 6 13%
Unknown 8 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2012.
All research outputs
#2,017,443
of 3,635,018 outputs
Outputs from BMC Cancer
#862
of 1,788 outputs
Outputs of similar age
#32,690
of 72,766 outputs
Outputs of similar age from BMC Cancer
#18
of 67 outputs
Altmetric has tracked 3,635,018 research outputs across all sources so far. This one is in the 26th percentile – i.e., 26% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,788 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,766 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.